Calretinin

A novel immunocytochemical marker for mesothelioma

Claudio Doglioni, Angelo P. Dei Tos, Licia Laurino, Paolo Luzzolino, Concetta Chiarelli, Marco R. Celio, Giuseppe Viale, M. RcPath

Research output: Contribution to journalArticle

399 Citations (Scopus)

Abstract

Immunohistochemistry is a powerful diagnostic adjunct in the differential diagnosis between malignant mesothelioma (especially of the epithelial type) and adenocarcinoma metastatic to the serous membranes. Most of the immunological probes commonly used, however, recognize antigens expressed by the epithelial malignancies and absent from mesothelial cells and mesotheliomas. Probes suitable for the positive identification of mesotheliomas are comparatively scarce and much less commonly used because of their reduced sensitivity and specificity, their unsuitability for staining routinely fixed and embedded tissues, or their lack of commercial availability. We now document that two different polyclonal antisera to calretinin consistently immunostain mesothelial cells and malignant mesotheliomas both in routinely fixed and embedded tissue sections and in cytological preparations of serous effusions. The diagnostic sensitivity of this novel immunocytochemical approach reached 100%, allowing immunostaining of all 44 mesotheliomas investigated, which included five biphasic and three sarcomatoid types. The specificity of calretinin immunoreactivity was checked against 294 adenocarcinomas of different origin (19 serosal metastases and 275 primary tumors potentially able to metastatize to serosal membranes) relevant for the discussion of the differential diagnosis with malignant mesothelioma: only 28 cases showed focal immunoreactivity for calretinin. We conclude that calretinin is a most useful marker for the positive identification of malignant mesotheliomas.

Original languageEnglish
Pages (from-to)1037-1046
Number of pages10
JournalAmerican Journal of Surgical Pathology
Volume20
Issue number9
DOIs
Publication statusPublished - Sep 1996

Fingerprint

Calbindin 2
Mesothelioma
Adenocarcinoma
Differential Diagnosis
Serous Membrane
Immune Sera
Neoplasms
Immunohistochemistry
Staining and Labeling
Neoplasm Metastasis
Antigens
Sensitivity and Specificity
Membranes
Malignant Mesothelioma

Keywords

  • Calretinin
  • Immunocytochemical markers for mesothelioma
  • Immunohistochemistry
  • Malignant mesothelioma
  • Metastatic adenocarcinoma

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine

Cite this

Doglioni, C., Dei Tos, A. P., Laurino, L., Luzzolino, P., Chiarelli, C., Celio, M. R., ... RcPath, M. (1996). Calretinin: A novel immunocytochemical marker for mesothelioma. American Journal of Surgical Pathology, 20(9), 1037-1046. https://doi.org/10.1097/00000478-199609000-00001

Calretinin : A novel immunocytochemical marker for mesothelioma. / Doglioni, Claudio; Dei Tos, Angelo P.; Laurino, Licia; Luzzolino, Paolo; Chiarelli, Concetta; Celio, Marco R.; Viale, Giuseppe; RcPath, M.

In: American Journal of Surgical Pathology, Vol. 20, No. 9, 09.1996, p. 1037-1046.

Research output: Contribution to journalArticle

Doglioni, C, Dei Tos, AP, Laurino, L, Luzzolino, P, Chiarelli, C, Celio, MR, Viale, G & RcPath, M 1996, 'Calretinin: A novel immunocytochemical marker for mesothelioma', American Journal of Surgical Pathology, vol. 20, no. 9, pp. 1037-1046. https://doi.org/10.1097/00000478-199609000-00001
Doglioni, Claudio ; Dei Tos, Angelo P. ; Laurino, Licia ; Luzzolino, Paolo ; Chiarelli, Concetta ; Celio, Marco R. ; Viale, Giuseppe ; RcPath, M. / Calretinin : A novel immunocytochemical marker for mesothelioma. In: American Journal of Surgical Pathology. 1996 ; Vol. 20, No. 9. pp. 1037-1046.
@article{8bd1a79b326e4368946f4582b63b8cdb,
title = "Calretinin: A novel immunocytochemical marker for mesothelioma",
abstract = "Immunohistochemistry is a powerful diagnostic adjunct in the differential diagnosis between malignant mesothelioma (especially of the epithelial type) and adenocarcinoma metastatic to the serous membranes. Most of the immunological probes commonly used, however, recognize antigens expressed by the epithelial malignancies and absent from mesothelial cells and mesotheliomas. Probes suitable for the positive identification of mesotheliomas are comparatively scarce and much less commonly used because of their reduced sensitivity and specificity, their unsuitability for staining routinely fixed and embedded tissues, or their lack of commercial availability. We now document that two different polyclonal antisera to calretinin consistently immunostain mesothelial cells and malignant mesotheliomas both in routinely fixed and embedded tissue sections and in cytological preparations of serous effusions. The diagnostic sensitivity of this novel immunocytochemical approach reached 100{\%}, allowing immunostaining of all 44 mesotheliomas investigated, which included five biphasic and three sarcomatoid types. The specificity of calretinin immunoreactivity was checked against 294 adenocarcinomas of different origin (19 serosal metastases and 275 primary tumors potentially able to metastatize to serosal membranes) relevant for the discussion of the differential diagnosis with malignant mesothelioma: only 28 cases showed focal immunoreactivity for calretinin. We conclude that calretinin is a most useful marker for the positive identification of malignant mesotheliomas.",
keywords = "Calretinin, Immunocytochemical markers for mesothelioma, Immunohistochemistry, Malignant mesothelioma, Metastatic adenocarcinoma",
author = "Claudio Doglioni and {Dei Tos}, {Angelo P.} and Licia Laurino and Paolo Luzzolino and Concetta Chiarelli and Celio, {Marco R.} and Giuseppe Viale and M. RcPath",
year = "1996",
month = "9",
doi = "10.1097/00000478-199609000-00001",
language = "English",
volume = "20",
pages = "1037--1046",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Calretinin

T2 - A novel immunocytochemical marker for mesothelioma

AU - Doglioni, Claudio

AU - Dei Tos, Angelo P.

AU - Laurino, Licia

AU - Luzzolino, Paolo

AU - Chiarelli, Concetta

AU - Celio, Marco R.

AU - Viale, Giuseppe

AU - RcPath, M.

PY - 1996/9

Y1 - 1996/9

N2 - Immunohistochemistry is a powerful diagnostic adjunct in the differential diagnosis between malignant mesothelioma (especially of the epithelial type) and adenocarcinoma metastatic to the serous membranes. Most of the immunological probes commonly used, however, recognize antigens expressed by the epithelial malignancies and absent from mesothelial cells and mesotheliomas. Probes suitable for the positive identification of mesotheliomas are comparatively scarce and much less commonly used because of their reduced sensitivity and specificity, their unsuitability for staining routinely fixed and embedded tissues, or their lack of commercial availability. We now document that two different polyclonal antisera to calretinin consistently immunostain mesothelial cells and malignant mesotheliomas both in routinely fixed and embedded tissue sections and in cytological preparations of serous effusions. The diagnostic sensitivity of this novel immunocytochemical approach reached 100%, allowing immunostaining of all 44 mesotheliomas investigated, which included five biphasic and three sarcomatoid types. The specificity of calretinin immunoreactivity was checked against 294 adenocarcinomas of different origin (19 serosal metastases and 275 primary tumors potentially able to metastatize to serosal membranes) relevant for the discussion of the differential diagnosis with malignant mesothelioma: only 28 cases showed focal immunoreactivity for calretinin. We conclude that calretinin is a most useful marker for the positive identification of malignant mesotheliomas.

AB - Immunohistochemistry is a powerful diagnostic adjunct in the differential diagnosis between malignant mesothelioma (especially of the epithelial type) and adenocarcinoma metastatic to the serous membranes. Most of the immunological probes commonly used, however, recognize antigens expressed by the epithelial malignancies and absent from mesothelial cells and mesotheliomas. Probes suitable for the positive identification of mesotheliomas are comparatively scarce and much less commonly used because of their reduced sensitivity and specificity, their unsuitability for staining routinely fixed and embedded tissues, or their lack of commercial availability. We now document that two different polyclonal antisera to calretinin consistently immunostain mesothelial cells and malignant mesotheliomas both in routinely fixed and embedded tissue sections and in cytological preparations of serous effusions. The diagnostic sensitivity of this novel immunocytochemical approach reached 100%, allowing immunostaining of all 44 mesotheliomas investigated, which included five biphasic and three sarcomatoid types. The specificity of calretinin immunoreactivity was checked against 294 adenocarcinomas of different origin (19 serosal metastases and 275 primary tumors potentially able to metastatize to serosal membranes) relevant for the discussion of the differential diagnosis with malignant mesothelioma: only 28 cases showed focal immunoreactivity for calretinin. We conclude that calretinin is a most useful marker for the positive identification of malignant mesotheliomas.

KW - Calretinin

KW - Immunocytochemical markers for mesothelioma

KW - Immunohistochemistry

KW - Malignant mesothelioma

KW - Metastatic adenocarcinoma

UR - http://www.scopus.com/inward/record.url?scp=0029819215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029819215&partnerID=8YFLogxK

U2 - 10.1097/00000478-199609000-00001

DO - 10.1097/00000478-199609000-00001

M3 - Article

VL - 20

SP - 1037

EP - 1046

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 9

ER -